Measuring Consumer Exposure Confounds US FDA’s Evaluation Of Cannabinoid Safety In Supplements
Executive Summary
Acting commissioner Woodcock reminds manufacturers and marketers that a consumer’s exposure to cannabidiol and other cannabinoids likely comes from using multiple products daily. “How do you control exposure of people in a nonprescription setting?”
You may also be interested in...
Congressional Report Highlights Lack of Mandatory Supplement Listing As DSHEA 2.0 Talks Continue
The Congressional Research Service published a dietary supplements report on 20 September that provides an overview of the industry and current regulatory issues, including ‘limitations’ in the US FDA’s authority over supplements and, in particular, the absence of mandatory product listing.
Church & Dwight Includes Cannabinoids Among Nair Bladeless Shave Luxury Treatment Choices
C&D launching three-product Nair Bladeless Shave line extension, including one with cannabinoids. First Response line Comfort Check extension contains three early tests and five pregnancy strips.
Room Available In US Pharma Industry For OTC Switch Leader: Has Perrigo Made A Reservation?
Acquiring HRA Pharma, Perrigo could take OTC switch lead, likely starting with HRA’s daily oral contraceptive before moving to numerous other potential candidates. Pharmas previously busy in switch have other priorities for their consumer health businesses.